Cpcm LLC Increases Stake in Bristol-Myers Squibb Company (BMY)

Marco Green
August 21, 2017

The company has market cap of $13.64 billion.

Bristol-Myers Squibb Company (NYSE:BMY) shares were trading lower by -0.62 percent ($-0.35) at $56.42 a piece in Friday's session. About shares traded. Brinker International, Inc.

Bristol-Myers Squibb (NYSE:BMY) last released its quarterly earnings data on Thursday, July 27th. It has underperformed by 16.48% the S&P500.

Blair William & Company decreased Archer (ADM) stake by 14.27% reported in 2016Q4 SEC filing. Shareholders of record on Friday, July 7th were issued a dividend of $0.39 per share. The company has market cap of $1.35 billion. Archer now has $23.37B valuation. Ariel Capital Limited Company accumulated 3,575 shares or 0.13% of the stock. About shares traded. Archer Daniels Midland Company (NYSE:ADM) has risen 8.16% since August 21, 2016 and is uptrending. It has underperformed by 6.56% the S&P500.

Since February 27, 2017, it had 1 buy, and 6 selling transactions for $9.91 million activity. ANDREOTTI LAMBERTO had sold 34,000 shares worth $1.91M on Monday, March 27. Of the 23 analysts surveyed by Reuters that track BMY 10 of them rate its stock a hold. $463,779 worth of Bristol-Myers Squibb Co (NYSE:BMY) was sold by Caldarella Joseph C on Wednesday, March 15. Shares for $5.27 million were sold by LEUNG SANDRA.

Among 15 analysts covering CA Technologies (NASDAQ:CA), 2 have Buy rating, 4 Sell and 9 Hold. Therefore 32% are positive. Estee Lauder had 61 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Citigroup with "Buy" on Tuesday, September 20. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. On Thursday, August 11 the stock rating was initiated by Atlantic Securities with "Neutral". Barclays Capital maintained it with "Equal-Weight" rating and $65 target in Friday, September 9 report. Deutsche Bank maintained Bristol-Myers Squibb Co (NYSE:BMY) rating on Monday, July 17. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned "Buy" rating by Jefferies on Monday, December 19. Guggenheim upgraded the stock to "Buy" rating in Wednesday, December 2 report. The firm earned "Hold" rating on Thursday, August 27 by Jefferies. The firm has "Underperform" rating by BMO Capital Markets given on Friday, July 28. PHM comes in with a P/S ratio of 0.94 that's below 1, potentially implying that it could be cheap relative to the overall sector (4387.36) and its peers (0.76). It improved, as 63 investors sold EL shares while 203 reduced holdings. Following the completion of the acquisition, the director now owns 18,000 shares in the company, valued at $1,006,920.

In related news, Director Theodore R. Samuels II acquired 6,000 shares of the business's stock in a transaction on Wednesday, August 2nd. 192.06 million shares or 1.13% less from 194.26 million shares in 2016Q3 were reported. Finally, Verus Financial Partners Inc. purchased a new stake in shares of Bristol-Myers Squibb during the first quarter valued at approximately $206,000. Cambiar Investors Ltd holds 1.16% or 1.16M shares. Carret Asset Mngmt Ltd Llc accumulated 0.48% or 42,942 shares. Bristol-Myers Squibb Company has $80 highest and $45 lowest target. Edge Wealth Ltd Liability Corporation has 0.07% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 3,290 shares. Delphi Mgmt Ma holds 36,769 shares. Spot Trading Lc reported 0.19% in Bristol-Myers Squibb Co (NYSE:BMY). Nichols Pratt Advisers Limited Liability Partnership Ma holds 0.06% or 11,700 shares in its portfolio. State Street Corp now owns 68,893,779 shares of the biopharmaceutical company's stock worth $3,746,446,000 after buying an additional 1,223,457 shares during the period. On average, analysts expect that Bristol-Myers Squibb Company will post $2.98 EPS for the current fiscal year.

According to the Recommendation Trends of the stock polled by Finviz, the company has a consensus recommendation of 2.4 out of the scale from 1 to 5 where 1 stands for Buy and 5 means Sell. It also upped Bwx Technologies Inc stake by 92,214 shares and now owns 258,379 shares. Ishares Tr Core Msci Eafe Etf (IEFA) was raised too.

Investors sentiment decreased to 0.83 in 2016 Q4. Its up 0.01, from 0.91 in 2016Q3. 66 funds opened positions while 180 raised stakes.

August 18, 2017Jazz Pharmaceuticals plc (JAZZ) ("Jazz Pharmaceuticals") announced an offering by Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), of $500 million aggregate principal amount of 1.50% exchangeable senior notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). During the same quarter a year ago, the firm posted $0.69 earnings per share. The firm has "Hold" rating by Jefferies given on Tuesday, June 14. Cmt Asset reported 91,562 shares. (NYSE:GPI). Price T Rowe Associates Md owns 9,060 shares for 0% of their portfolio. Bessemer Grp holds 14,282 shares or 0% of its portfolio. Regions holds 962,795 shares. Park Oh accumulated 0.18% or 49,900 shares. Nikko Asset Mngmt Americas holds 1.42% or 387,699 shares. Paragon Management Limited Company invested in 0.1% or 5,249 shares.

Other reports by Click Lancashire

Discuss This Article